Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025

Research progress in active substances and their mechanisms of action against porcine epidemic diarrhea virus.

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYu LiuSSShu-Jem SuZWZiqian Wang

Discussion

Loading...

Member takes

Overview

Review highlights the role of active substances in enhancing immune function against porcine epidemic diarrhea virus, suggesting potential for new antiviral drugs.

Key Points

  • Active substances enhance immune function against porcine epidemic diarrhea virus (PEDV), preventing severe outcomes.
  • Strategies include regulating intracellular signaling pathways and targeting viral proteins to combat PEDV effectively.
  • The diversity of PEDV strains complicates conventional vaccine effectiveness, necessitating novel antiviral approaches.
  • Preventing PEDV resistance is critical to safeguard both livestock health and reduce risks of interspecies transmission.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/68c1bb7854b1d3bfb60edd0ahttps://doi.org/10.13345/j.cjb.250129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recent Advances in Virus–Host Interactions, Antiviral Bioactive Compounds, and Breeding for Disease Resistance of Porcine Epidemic Diarrhea Virus2026
  2. 2Porcine Epidemic Diarrhea: Insights and Progress on Vaccines2024 · 28 citations
  3. 3PEDV Structural Proteins with Emphasis on M Protein as an Immunomodulatory Factor in Porcine Innate Immunity2025
  4. 4How Does Porcine Epidemic Diarrhea Virus Escape Host Innate Immunity?2025 · 2 citations
  5. 5Integrated Metabolomic and Transcriptomic Analysis Reveals Host Response Mechanisms to Porcine Epidemic Diarrhea Virus Infection in Pigs2026